Table of Contents
Chapter 1. Global Consumer Healthcare Market Executive Summary
1.1. Global Consumer Healthcare Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Consumer Healthcare Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Consumer Healthcare Market Dynamics
3.1. Market Drivers
3.1.1. Awareness of Lifestyle Diseases
3.1.2. Increasing Demand for Preventive Health Solutions
3.1.3. Growth in Telehealth and Online Platforms
3.2. Market Challenges
3.2.1. Presence of Counterfeit Pharmaceuticals
3.2.2. Regulatory and Compliance Challenges
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Growth in Health-Conscious Consumer Base
3.3.3. Integration of Advanced Technologies
Chapter 4. Global Consumer Healthcare Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Consumer Healthcare Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Consumer Healthcare Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. OTC Pharmaceuticals
5.2.2. Dietary Supplements
Chapter 6. Global Consumer Healthcare Market Size & Forecasts by Distribution Channel 2022-2032
6.1. Segment Dashboard
6.2. Global Consumer Healthcare Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Offline
6.2.2. Online
Chapter 7. Global Consumer Healthcare Market Size & Forecasts by Region 2022-2032
7.1. North America Consumer Healthcare Market
7.1.1. U.S. Consumer Healthcare Market
7.1.1.1. Product breakdown size & forecasts, 2022-2032
7.1.1.2. Distribution Channel breakdown size & forecasts, 2022-2032
7.1.2. Canada Consumer Healthcare Market
7.2. Europe Consumer Healthcare Market
7.2.1. U.K. Consumer Healthcare Market
7.2.2. Germany Consumer Healthcare Market
7.2.3. France Consumer Healthcare Market
7.2.4. Spain Consumer Healthcare Market
7.2.5. Italy Consumer Healthcare Market
7.2.6. Rest of Europe Consumer Healthcare Market
7.3. Asia-Pacific Consumer Healthcare Market
7.3.1. China Consumer Healthcare Market
7.3.2. India Consumer Healthcare Market
7.3.3. Japan Consumer Healthcare Market
7.3.4. Australia Consumer Healthcare Market
7.3.5. South Korea Consumer Healthcare Market
7.3.6. Rest of Asia Pacific Consumer Healthcare Market
7.4. Latin America Consumer Healthcare Market
7.4.1. Brazil Consumer Healthcare Market
7.4.2. Mexico Consumer Healthcare Market
7.4.3. Rest of Latin America Consumer Healthcare Market
7.5. Middle East & Africa Consumer Healthcare Market
7.5.1. Saudi Arabia Consumer Healthcare Market
7.5.2. South Africa Consumer Healthcare Market
7.5.3. Rest of Middle East & Africa Consumer Healthcare Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Amway Corp.
8.3.3. BASF SE
8.3.4. Bayer AG
8.3.5. Boehringer Ingelheim International GmbH
8.3.6. Chr Hansen Holding AS
8.3.7. Danone SA
8.3.8. Eisai Co. Ltd.
8.3.9. Glanbia plc
8.3.10. GlaxoSmithKline Plc
8.3.11. Herbalife International of America Inc.
8.3.12. Himalaya Global Holdings Ltd.
8.3.13. Johnson and Johnson Services Inc.
8.3.14. Kellogg Co.
8.3.15. Koninklijke DSM NV
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes